通过超结构分析了解质瘤的发病过程
Muhammad Sulman1, John Paul Aboubechara2, Mones S Abu-Asab3
1School of Medicine, University of California, Davis, CA, USA.
Ultrastructural pathology
|September 11, 2025
概括
超结构分析揭示了脂质积累,线粒体和膜异常,以及质瘤中的血管变化. 这些发现为结质瘤病理学和潜在的治疗策略提供了洞察力.
科学领域:
- 神经瘤学神经瘤学
- 细胞病理学 细胞病理学
- 瘤微环境研究研究
背景情况:
- 质瘤是最常见的恶性脑瘤,起源于质细胞.
- 质母细胞瘤是一种质瘤,预后不好,平均存活时间为15个月.
- 了解质瘤的超结构和微环境对于推进治疗至关重要.
研究的目的:
- 分析最近在质瘤的超结构病理学的发展.
- 要突出脂质积累和相关细胞变化的作用.
- 检查质瘤中的血管异常和微环境特征.
主要方法:
- 高分辨率电子显微镜用于超结构分析 (UA).
- 检查细胞和亚细胞特征.
- 对瘤微环境的分析,包括血管结构和细胞组件.
主要成果:
- 在质瘤中观察到丰富的细胞内和细胞外脂质.
- 异常的线粒体结构和破坏的细胞膜被注意到.
- 显著的血管干扰,包括不典型的血管壁和瘤细胞模仿内皮细胞.
- 在微环境中多核巨细胞和染色体外DNA的高流行率.
结论:
- 超结构分析提供了对质瘤病变发生的关键见解.
- 脂质变化,线粒体功能障碍和血管异常是其关键特征.
- 这些发现对未来的质瘤研究,诊断和治疗有意义.
相关概念视频
Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...


